Related Experiment Video
Updated: Jul 7, 2026
09:54
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Murine models for HIV vaccination and challenge
Andreas Boberg1, Andreas Bråve, Susanne Johansson
1Swedish Institute for Infectious Disease Control and Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden. andreas.boberg@smi.ki.se
Expert Review of Vaccines
|February 7, 2008
Summary
Developing small-animal models is crucial for studying human immunodeficiency virus type 1 (HIV-1) infection and vaccine efficacy. Murine models, particularly cell-based challenge models, offer a promising alternative to expensive primate studies for HIV-1 research.
Area of Science:
- Virology and Immunology
- Infectious Diseases
- Vaccine Development
Background:
- Human immunodeficiency virus type 1 (HIV-1) primarily infects humans and chimpanzees.
- Current primate models (SIV/SHIV in macaques) have limitations in fully mimicking HIV-1 infection and vaccination, and are costly.
- There is a significant need for accessible small-animal models to study HIV-1 infection, immunity, and vaccine efficacy.
Purpose of the Study:
- To review available murine models for studying HIV-1 infection.
- To emphasize the utility of the HIV-1-infected-cell challenge model for evaluating candidate HIV-1 vaccines.
- To identify key factors influencing vaccine efficacy in preclinical models.
Main Methods:
- Review of existing literature on murine models for HIV-1 research.
- Focus on the HIV-1-infected-cell challenge model.
- Analysis of factors contributing to vaccine efficacy, including DNA constructs, adjuvants, and antibody-mediated eradication.
Main Results:
- Murine models provide a viable alternative for studying HIV-1 infection and immunity.
- The cell-based challenge model demonstrated the importance of combining plasmid DNA from multiple HIV-1 clades.
- Adjuvants enhancing innate and induced immunity, and drug-conjugated antibodies for HIV eradication, were identified as critical factors.
Conclusions:
- Murine models, especially the cell-based challenge system, are valuable tools for HIV-1 research and vaccine evaluation.
- Optimizing DNA vaccine constructs, utilizing potent adjuvants, and exploring antibody-based therapies are key strategies for effective HIV-1 control.
- These findings contribute to the development of more effective HIV-1 vaccines and treatments.
